Germany’s Online Pharmacy Market: Revenue Projections to 2026

The German e-pharmacy market continues its expansion, driven by evolving consumer preferences and a robust digital infrastructure. This segment represents a significant growth vector within the broader DACH healthcare retail landscape, warranting close examination of its trajectory.

German E-Pharmacy Market Size and Growth Trajectory

The German online pharmacy sector, predominantly comprising over-the-counter (OTC) medications, health products, and beauty items, demonstrates consistent growth. For 2023, the market generated an estimated revenue of €2.8 billion within these categories. Projections indicate a substantial increase, with the market forecast to reach €4.1 billion by 2026. This represents a Compound Annual Growth Rate (CAGR) of approximately 13.5% over the three-year period.

While online channels currently constitute a smaller fraction of the total German pharmacy market, which stood at approximately €60 billion in 2023 (including prescription drugs dispensed via traditional Apotheken), their share is expanding. The online segment’s share of the total market, focusing on addressable non-prescription categories, is projected to grow from 4.7% in 2023 to 6.8% by 2026. This growth is primarily fueled by increasing consumer adoption of digital purchasing channels for health-related products.

The following table provides a summary of key market metrics:

Note: Revenue figures primarily encompass OTC drugs, dietary supplements, cosmetics, and medical devices available for mail-order in Germany. They exclude prescription drugs (Rx) due to existing regulatory restrictions on their online sale and mail-order.

Key Market Drivers and Regulatory Framework

The expansion of the German e-pharmacy market is underpinned by several factors. Digitalization trends continue to shift consumer purchasing habits, with an increasing preference for the convenience and broader product selection offered by online platforms. Demographic shifts, including an aging population and a heightened general health consciousness, also contribute to demand for accessible health products. Furthermore, the ability to compare prices for OTC products more readily online contributes to consumer adoption.

The regulatory landscape in Germany plays a significant role in shaping the e-pharmacy market’s structure, particularly concerning prescription drugs. The Arzneimittelgesetz (AMG) governs the distribution and sale of pharmaceuticals. A pivotal development was the 2016 ruling by the European Court of Justice (EuGH), which initially allowed foreign online pharmacies to offer rebates on prescription drugs to German consumers. However, subsequent German legislation effectively countered this by banning rebates for prescription drugs via mail order for both domestic and foreign pharmacies, aiming to ensure equal competitive conditions for all Apotheken.

Crucially, the Versandhandelsverbot für verschreibungspflichtige Arzneimittel (mail-order ban for prescription-only medicines) remains largely in effect. This restriction channels the vast majority of prescription drug dispensing through traditional brick-and-mortar Apotheken and limits the online pharmacy market primarily to OTC medications, dietary supplements (Nahrungsergänzungsmittel), medical devices, and health-related non-pharmaceutical products. Any future changes to this regulatory framework would significantly alter the market’s potential trajectory.

Competitive Landscape and Market Share Dynamics

The German online pharmacy market is characterized by a concentrated competitive landscape, with a few major players holding substantial market share. Leading entities include Shop Apotheke Europe and the Zur Rose Group (operating brands such as DocMorris and Medpex). These companies have established strong brand recognition and logistical capabilities.

Based on recent market assessments, Shop Apotheke Europe, including its acquired brands like Redpoint, holds an estimated market share ranging from 35% to 40% in the German online OTC and health products segment. The Zur Rose Group, through its various subsidiaries, commands a comparable share, estimated between 30% and 35%. Other online pharmacies, such as Aponeo and Sanicare, collectively account for the remaining market share.

The market has also seen consolidation activities, with larger players acquiring smaller competitors to expand their customer base and product portfolios. While traditional Apotheken continue to dominate the overall German pharmaceutical retail market, particularly for prescription drugs, the online channel is steadily gaining share in the addressable OTC and non-prescription segments. The competitive intensity is driven by pricing strategies for non-regulated products, extensive product ranges, and customer service propositions.

Consumer Behavior and Product Segment Preferences

German consumers engaging with online pharmacies primarily seek convenience, competitive pricing for non-prescription items, and a broader selection of products compared to local Apotheken. The main product categories purchased online include:

• Over-the-Counter (OTC) Drugs: Painkillers, cold and flu remedies, allergy medications, and digestive aids are frequently bought online.
• Dietary Supplements (Nahrungsergänzungsmittel): Vitamins, minerals, and other health supplements constitute a significant portion of online sales.
• Cosmetics and Personal Care: Skincare, haircare, and other beauty products, often with a pharmaceutical or dermatological focus, are popular items.
• Medical Devices and Health Aids: Products like blood pressure monitors, wound care supplies, and orthopedic aids also see considerable online demand.

Consumer demographics indicate that while younger age groups were early adopters of e-pharmacy services, older demographics are increasingly utilizing online channels for repeat purchases of non-prescription items, driven by ease of access and home delivery options. The average order value (AOV) in the German e-pharmacy market typically ranges from €55 to €65, with a slight upward trend projected towards €60-€70 by 2026 as consumers become more comfortable with larger basket sizes for health-related purchases. This behavior underscores a growing trust in online channels for health product procurement within Germany.

Frequently Asked Questions

What is the projected revenue for Germany’s online pharmacy market in 2026? The German online pharmacy market is forecast to reach €4.1 billion by 2026. This figure primarily covers over-the-counter (OTC) medications, health products, and beauty items.

What is the Compound Annual Growth Rate (CAGR) for German e-pharmacy revenue from 2023 to 2026? The German e-pharmacy market is projected to grow at a Compound Annual Growth Rate (CAGR) of approximately 13.5% between 2023 and 2026. This growth is anticipated to increase revenue from €2.8 billion in 2023 to €4.1 billion by 2026.

Does the 2026 revenue forecast for German e-pharmacy include prescription drugs? No, the 2026 revenue forecast for German e-pharmacy primarily excludes prescription drugs (Rx). Existing regulatory restrictions, particularly the Versandhandelsverbot für verschreibungspflichtige Arzneimittel, limit the online market to OTC medications, dietary supplements, medical devices, and health-related non-pharmaceutical products.

What share of the total German pharmacy market is the online segment expected to hold by 2026? The online segment’s share of the total German pharmacy market, focusing on addressable non-prescription categories, is projected to grow from 4.7% in 2023 to 6.8% by 2026. This expansion is driven by increasing consumer adoption of digital purchasing channels for health-related products.

For deeper strategic analysis, see our full report.

The German e-pharmacy market is projected to achieve revenues of €4.1 billion by 2